questionsmedicales.fr
Actions chimiques et utilisations
Utilisations spécialisées de produits chimiques
Agents séquestrants
Agents séquestrants : Questions médicales fréquentes
Termes MeSH sélectionnés :
Angiotensin-Converting Enzyme 2
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Agents séquestrants : Questions médicales les plus fréquentes",
"headline": "Agents séquestrants : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Agents séquestrants : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-05-03",
"dateModified": "2025-04-28",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Agents séquestrants"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Utilisations spécialisées de produits chimiques",
"url": "https://questionsmedicales.fr/mesh/D020313",
"about": {
"@type": "MedicalCondition",
"name": "Utilisations spécialisées de produits chimiques",
"code": {
"@type": "MedicalCode",
"code": "D020313",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.720"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Chélateurs",
"alternateName": "Chelating Agents",
"url": "https://questionsmedicales.fr/mesh/D002614",
"about": {
"@type": "MedicalCondition",
"name": "Chélateurs",
"code": {
"@type": "MedicalCode",
"code": "D002614",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.720.832.500"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Agents chélateurs du calcium",
"alternateName": "Calcium Chelating Agents",
"url": "https://questionsmedicales.fr/mesh/D065096",
"about": {
"@type": "MedicalCondition",
"name": "Agents chélateurs du calcium",
"code": {
"@type": "MedicalCode",
"code": "D065096",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.720.832.500.204"
}
}
},
{
"@type": "MedicalWebPage",
"name": "Agents chélateurs du fer",
"alternateName": "Iron Chelating Agents",
"url": "https://questionsmedicales.fr/mesh/D007502",
"about": {
"@type": "MedicalCondition",
"name": "Agents chélateurs du fer",
"code": {
"@type": "MedicalCode",
"code": "D007502",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.720.832.500.410"
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Sidérophores",
"alternateName": "Siderophores",
"url": "https://questionsmedicales.fr/mesh/D017262",
"about": {
"@type": "MedicalCondition",
"name": "Sidérophores",
"code": {
"@type": "MedicalCode",
"code": "D017262",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.720.832.500.410.750"
}
}
}
]
},
{
"@type": "MedicalWebPage",
"name": "Sidérophores",
"alternateName": "Siderophores",
"url": "https://questionsmedicales.fr/mesh/D017262",
"about": {
"@type": "MedicalCondition",
"name": "Sidérophores",
"code": {
"@type": "MedicalCode",
"code": "D017262",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D27.720.832.500.410.750"
}
}
}
]
}
],
"about": {
"@type": "MedicalCondition",
"name": "Agents séquestrants",
"alternateName": "Sequestering Agents",
"code": {
"@type": "MedicalCode",
"code": "D064449",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Xueli Cao",
"url": "https://questionsmedicales.fr/author/Xueli%20Cao",
"affiliation": {
"@type": "Organization",
"name": "Beijing Advanced Innovation Center for Soft Matter Science and Engineering, State Key Laboratory of Chemical Resource Engineering, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China."
}
},
{
"@type": "Person",
"name": "Yu Xiao",
"url": "https://questionsmedicales.fr/author/Yu%20Xiao",
"affiliation": {
"@type": "Organization",
"name": "Ministry of Education Key Laboratory of Protein Science, Beijing Advanced Innovation Center for Structural Biology, Beijing Frontier Research Center for Biological Structure, School of Life Sciences, Tsinghua University, Tsinghua-Peking Center for Life Sciences, Beijing 100084, China."
}
},
{
"@type": "Person",
"name": "Erin Huiting",
"url": "https://questionsmedicales.fr/author/Erin%20Huiting",
"affiliation": {
"@type": "Organization",
"name": "Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, CA 94158, USA."
}
},
{
"@type": "Person",
"name": "Dong Li",
"url": "https://questionsmedicales.fr/author/Dong%20Li",
"affiliation": {
"@type": "Organization",
"name": "Beijing Advanced Innovation Center for Soft Matter Science and Engineering, State Key Laboratory of Chemical Resource Engineering, College of Life Science and Technology, Beijing University of Chemical Technology, Beijing 100029, China."
}
},
{
"@type": "Person",
"name": "Jie Ren",
"url": "https://questionsmedicales.fr/author/Jie%20Ren",
"affiliation": {
"@type": "Organization",
"name": "State Key Laboratory for Biology of Plant Diseases and Insect Pests, Ministry of Agriculture, Institute of Plant Protection, Chinese Academy of Agricultural Sciences, Beijing 100081, China."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Correlation of Angiotensin-converting Enzyme 2 Gene (rs1514283) Polymorphism with the Incidence of COVID-19.",
"datePublished": "2022-06-08",
"url": "https://questionsmedicales.fr/article/35686904",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.47750/jptcp.2022.922"
}
},
{
"@type": "ScholarlyArticle",
"name": "The Race for ACE: Targeting Angiotensin-Converting Enzymes (ACE) in SARS-CoV-2 Infection.",
"datePublished": "2022-05-27",
"url": "https://questionsmedicales.fr/article/35685188",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1155/2022/2549063"
}
},
{
"@type": "ScholarlyArticle",
"name": "Expression of angiotensin converting enzyme 2 mRNA in different SARS-CoV-2 infection states and times.",
"datePublished": "2023-01-10",
"url": "https://questionsmedicales.fr/article/36625725",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/07391102.2022.2160821"
}
},
{
"@type": "ScholarlyArticle",
"name": "Angiotensin-Converting Enzyme-2 (",
"datePublished": "2023-12-21",
"url": "https://questionsmedicales.fr/article/38155729",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1155/2023/6384208"
}
},
{
"@type": "ScholarlyArticle",
"name": "Association and functional analysis of angiotensin-converting enzyme 2 genetic variants with the pathogenesis of pre-eclampsia.",
"datePublished": "2022-11-07",
"url": "https://questionsmedicales.fr/article/36419766",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fendo.2022.926512"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Actions chimiques et utilisations",
"item": "https://questionsmedicales.fr/mesh/D020164"
},
{
"@type": "ListItem",
"position": 3,
"name": "Utilisations spécialisées de produits chimiques",
"item": "https://questionsmedicales.fr/mesh/D020313"
},
{
"@type": "ListItem",
"position": 4,
"name": "Agents séquestrants",
"item": "https://questionsmedicales.fr/mesh/D064449"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Agents séquestrants - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Agents séquestrants",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-05",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Agents séquestrants",
"description": "Comment diagnostiquer une intoxication aux métaux lourds ?\nQuels examens pour évaluer l'efficacité d'un agent séquestrant ?\nQuels symptômes indiquent un besoin d'agents séquestrants ?\nComment identifier une carence nutritionnelle ?\nQuels signes d'overdose d'agents séquestrants ?",
"url": "https://questionsmedicales.fr/mesh/D064449?mesh_terms=Angiotensin-Converting+Enzyme+2&page=2#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Agents séquestrants",
"description": "Quels symptômes d'une carence en fer ?\nComment reconnaître une toxicité au plomb ?\nQuels signes d'une carence en calcium ?\nQuels symptômes d'une intoxication au mercure ?\nComment se manifeste une carence en potassium ?",
"url": "https://questionsmedicales.fr/mesh/D064449?mesh_terms=Angiotensin-Converting+Enzyme+2&page=2#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Agents séquestrants",
"description": "Comment prévenir les carences nutritionnelles ?\nQuelles mesures pour éviter l'exposition aux métaux lourds ?\nComment réduire le cholestérol par l'alimentation ?\nQuels aliments riches en calcium pour la prévention ?\nComment éviter les effets secondaires des séquestrants ?",
"url": "https://questionsmedicales.fr/mesh/D064449?mesh_terms=Angiotensin-Converting+Enzyme+2&page=2#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Agents séquestrants",
"description": "Quels agents séquestrants pour le cholestérol ?\nComment fonctionnent les agents séquestrants ?\nQuels sont les effets secondaires des agents séquestrants ?\nComment administrer un agent séquestrant ?\nQuels agents séquestrants pour les métaux lourds ?",
"url": "https://questionsmedicales.fr/mesh/D064449?mesh_terms=Angiotensin-Converting+Enzyme+2&page=2#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Agents séquestrants",
"description": "Quelles complications d'une surconsommation d'agents séquestrants ?\nQuels risques d'une utilisation prolongée ?\nComment les agents séquestrants affectent-ils l'absorption des médicaments ?\nQuelles complications liées à l'intoxication au plomb ?\nQuels effets à long terme des agents séquestrants ?",
"url": "https://questionsmedicales.fr/mesh/D064449?mesh_terms=Angiotensin-Converting+Enzyme+2&page=2#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Agents séquestrants",
"description": "Quels facteurs augmentent le risque de carences ?\nQui est à risque d'intoxication au mercure ?\nQuels groupes sont vulnérables aux carences en calcium ?\nQuels comportements augmentent le risque d'intoxication aux métaux ?\nQuels facteurs influencent l'absorption des nutriments ?",
"url": "https://questionsmedicales.fr/mesh/D064449?mesh_terms=Angiotensin-Converting+Enzyme+2&page=2#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une intoxication aux métaux lourds ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins et urinaires peuvent détecter la présence de métaux lourds."
}
},
{
"@type": "Question",
"name": "Quels examens pour évaluer l'efficacité d'un agent séquestrant ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des analyses biochimiques peuvent mesurer les niveaux de nutriments ou toxines."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent un besoin d'agents séquestrants ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes comme des douleurs abdominales ou des troubles digestifs peuvent indiquer un besoin."
}
},
{
"@type": "Question",
"name": "Comment identifier une carence nutritionnelle ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins peuvent révéler des carences en vitamines ou minéraux."
}
},
{
"@type": "Question",
"name": "Quels signes d'overdose d'agents séquestrants ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des nausées, vomissements ou diarrhées peuvent signaler une overdose."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une carence en fer ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fatigue, pâleur, essoufflement et vertiges sont des symptômes courants."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une toxicité au plomb ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs abdominales, des troubles neurologiques et des anémies peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quels signes d'une carence en calcium ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des crampes musculaires, des engourdissements et des troubles de l'humeur peuvent apparaître."
}
},
{
"@type": "Question",
"name": "Quels symptômes d'une intoxication au mercure ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tremblements, des troubles de la mémoire et des problèmes de vision peuvent se manifester."
}
},
{
"@type": "Question",
"name": "Comment se manifeste une carence en potassium ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des faiblesses musculaires, des palpitations et des troubles du rythme cardiaque peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment prévenir les carences nutritionnelles ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée et variée est essentielle pour éviter les carences."
}
},
{
"@type": "Question",
"name": "Quelles mesures pour éviter l'exposition aux métaux lourds ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Éviter les aliments contaminés et utiliser des filtres à eau peut réduire l'exposition."
}
},
{
"@type": "Question",
"name": "Comment réduire le cholestérol par l'alimentation ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consommer des fibres solubles et limiter les graisses saturées aide à réduire le cholestérol."
}
},
{
"@type": "Question",
"name": "Quels aliments riches en calcium pour la prévention ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les produits laitiers, les légumes verts et les noix sont de bonnes sources de calcium."
}
},
{
"@type": "Question",
"name": "Comment éviter les effets secondaires des séquestrants ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Prendre les agents séquestrants avec suffisamment d'eau et suivre les recommandations médicales."
}
},
{
"@type": "Question",
"name": "Quels agents séquestrants pour le cholestérol ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les résines comme le cholestyramine sont utilisées pour réduire le cholestérol sanguin."
}
},
{
"@type": "Question",
"name": "Comment fonctionnent les agents séquestrants ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils se lient aux substances dans l'intestin, empêchant leur absorption dans le sang."
}
},
{
"@type": "Question",
"name": "Quels sont les effets secondaires des agents séquestrants ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des effets comme des ballonnements, des nausées et des troubles digestifs peuvent survenir."
}
},
{
"@type": "Question",
"name": "Comment administrer un agent séquestrant ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils sont généralement pris par voie orale, souvent mélangés à des liquides."
}
},
{
"@type": "Question",
"name": "Quels agents séquestrants pour les métaux lourds ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des agents comme l'EDTA sont utilisés pour traiter les intoxications aux métaux lourds."
}
},
{
"@type": "Question",
"name": "Quelles complications d'une surconsommation d'agents séquestrants ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une surconsommation peut entraîner des carences nutritionnelles et des troubles digestifs."
}
},
{
"@type": "Question",
"name": "Quels risques d'une utilisation prolongée ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une utilisation prolongée peut causer des déséquilibres électrolytiques et des carences."
}
},
{
"@type": "Question",
"name": "Comment les agents séquestrants affectent-ils l'absorption des médicaments ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent réduire l'absorption de certains médicaments, diminuant leur efficacité."
}
},
{
"@type": "Question",
"name": "Quelles complications liées à l'intoxication au plomb ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications neurologiques, rénales et cardiovasculaires peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quels effets à long terme des agents séquestrants ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des effets à long terme peuvent inclure des carences nutritionnelles et des troubles métaboliques."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque de carences ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation déséquilibrée, des maladies chroniques et des régimes restrictifs augmentent le risque."
}
},
{
"@type": "Question",
"name": "Qui est à risque d'intoxication au mercure ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes consommant régulièrement des poissons contaminés sont à risque élevé."
}
},
{
"@type": "Question",
"name": "Quels groupes sont vulnérables aux carences en calcium ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes âgées, les femmes enceintes et les végétariens peuvent être plus vulnérables."
}
},
{
"@type": "Question",
"name": "Quels comportements augmentent le risque d'intoxication aux métaux ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Travailler dans des environnements contaminés ou utiliser des produits non réglementés augmente le risque."
}
},
{
"@type": "Question",
"name": "Quels facteurs influencent l'absorption des nutriments ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge, la santé digestive et les interactions médicamenteuses influencent l'absorption."
}
}
]
}
]
}
It has been a busy year for coronaviruses, with the most recent one causing severe coronavirus illness in 2019 (COVID-19). It is broadly distributed in many human tissues and organs as the potential S...
The SARS-CoV-2 virus is spreading around the world, and its clinical manifestation COVID-19 is challenging medical, economic, and social systems. With more and more scientific and social media reports...
To measure the expression of angiotensin converting enzyme 2 (ACE2) mRNA in SARS-CoV-2 infection with different infection status and at different stages during infection, we used RT-qP CR to measure t...
The host genetic background is a crucial factor that underlies the interindividual variability of COVID-19 fatality and outcomes. Angiotensin-converting enzyme-2 (...
The identified genotypes and their alleles were significantly correlated with COVID-19 clinical deterioration as follows:...
The aim of this study was to investigate the relationship between potential functional single-nucleotide polymorphisms (SNPs) of the angiotensin-converting enzyme 2 (...
A case-control study was conducted involving 327 PE cases and 591 age-matched, normal, singleton pregnant women. Potential functional...
After adjusting for age and body mass index (BMI), unconditional logistic regression analysis showed that rs2106809 A>G was significantly associated with PE risk (AG...
The...
Angiotensin-converting enzyme 2 (ACE2) expressions and its modulation are of great interest as being a key receptor for severe acute respiratory syndrome coronavirus 2 (SARS-CoV2) and the protective a...
We performed a meta-analysis, extracting the data for ACE2 expression in human subjects with various diseases, including SARS-CoV2 infection without or with co-morbidity. The Preferred Reporting Items...
Angiotensin-converting enzyme 2 expression was significantly increased in all diseases. There was an elevated level of ACE2, especially membrane-bound ACE2, in COVID-19 patients compared to healthy co...
It was observed that utilizing the ACE2 by SARS-CoV2 for its entry and its consequence leads to several complications. So there is a need to investigate the underlying mechanism along with novel thera...
Angiotensin I-converting enzyme type 2 (ACE2), a pivotal SARS-CoV-2 receptor, has been shown to be expressed in multiple cells, including human pancreatic beta-cells. A putative bidirectional relation...
Angiotensin I-converting enzyme type 2 immunofluorescence analysis using two antibodies alongside insulin staining was performed on formalin-fixed paraffin embedded pancreatic sections obtained from n...
Using two different antibodies, ACE2 expression was confirmed in beta-cells and in pancreas microvasculature. Angiotensin I-converting enzyme type 2 expression was increased in pancreatic islets of T2...
Higher ACE2 expression in T2D islets might increase their susceptibility to SARS-CoV-2 infection during COVID-19 in T2D patients, thus worsening glycometabolic outcomes and disease severity....
Science is digging for the varied presentation of COVID-19 patients exposed to the same risk factors, and medical conditions may be influenced by the presence of polymorphic genetic variants. This stu...
SARS-CoV-2 enters human cells through its main receptor, angiotensin-converting enzyme 2 (ACE2), which constitutes a limiting factor of infection. Recent findings demonstrating novel ACE2 isoforms imp...
COVID-19 caused by SARS-CoV-2 has spread around the world. The receptor-binding domain (RBD) of the spike protein of SARS-CoV-2 is a critical component that directly interacts with host ACE2. Here, we...